Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.26 +0.10 (+4.40%)
At close: Oct 20, 2026 · 4:00 PM EDT

Eledon Pharmaceuticals (ELDN) Research & Development (2013 - 2026)

Updated

Eledon Pharmaceuticals' Research & Development came in at $18.23 million for Q2 2026, down 10.1% from $20.28 million a year earlier but up 6.0% from the prior quarter.

Analysis

Eledon Pharmaceuticals (ELDN) Research & Development (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Eledon Pharmaceuticals reported Research & Development of $70.67 million, up 3.5% year-over-year; for FY2024, it came in at $51.96 million, up 71.4% from FY2023.

  • Research & Development has increased in each of the last four years, with a five-year compound annual growth rate of 44.9% (FY2019 to FY2024).
  • Going back by year, Research & Development was $30.31 million in FY2023 (+11.9%), $27.08 million in FY2022 (+14.1%), $23.74 million in FY2021 (+287.1%) and $6.13 million in FY2020 (-24.6%).
  • The five-year range for quarterly Research & Development is $5.74 million (Q2 2022) to $20.28 million (Q2 2025).
  • Year-over-year, Research & Development increased in five of the last seven quarters, with growth averaging 64.7%.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 153.7%), and the weakest in Q2 2026 (a decline of 10.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 3.65 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.34 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 4.05 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 1.76 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 2.81 Bn
10 Eledon Pharmaceuticals 257.38 Mn 168.58 Mn - 18.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.23 Mn
Mar 31, 2026 17.20 Mn
Sep 30, 2025 14.97 Mn
Jun 30, 2025 20.28 Mn
Mar 31, 2025 13.53 Mn
Dec 31, 2024 17.93 Mn
Sep 30, 2024 16.52 Mn
Jun 30, 2024 10.11 Mn
Mar 31, 2024 7.41 Mn
Dec 31, 2023 7.07 Mn
Sep 30, 2023 7.93 Mn
Jun 30, 2023 7.20 Mn
Mar 31, 2023 8.11 Mn
Dec 31, 2022 7.25 Mn
Sep 30, 2022 7.45 Mn
Jun 30, 2022 5.74 Mn
Mar 31, 2022 6.64 Mn
Dec 31, 2021 6.18 Mn
Sep 30, 2021 7.66 Mn
Jun 30, 2021 4.24 Mn
API Access

Eledon Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ELDN&period=max&api_key=YOUR_API_KEY